Shot in the arm or a shot in the dark? Complacency fears over Covid-19 vaccine equity market boost

Market rally too premature, experts warn

Mike Sheen
clock • 5 min read

The equity market rally sparked by news of Pfizer's Covid-19 vaccine breakthrough last week may have been "over the top", with significant hurdles still ahead for investors, despite growing confidence among value-focused fund groups that their investment style may finally be about to break its losing streak.

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Global

Global dividends hit record $1.14trn in H1 2025

Global dividends hit record $1.14trn in H1 2025

UK lags behind global average

Michael Nelson
clock 03 October 2025 • 2 min read
Fund managers at their 'most bullish' since February as trade war risks fade

Fund managers at their 'most bullish' since February as trade war risks fade

BofA global fund manager survey

Michael Nelson
clock 17 September 2025 • 1 min read
UK retail investors tilt back towards the US as confidence returns

UK retail investors tilt back towards the US as confidence returns

More guarded on Magnificent Seven

Michael Nelson
clock 17 September 2025 • 2 min read
Trustpilot